肠道LGR4信号改变了细菌转位,肝内微生物群组成和1型干扰素表达在小鼠肝纤维化中的表达
Junyan Gao1, Bangtao Chen2, Cheng Chen3
1Department of Basic Medicine, Changzhi Medical College, Changzhi, 046000, China.
Inflammation
|December 20, 2025
概括
肠道LGR4信号减弱会通过增加肠道透性和改变肝脏微生物群,使肝纤维化 (LF) 恶化. 恢复乳杆菌水平和增加1型干扰素 (IFN1) 可以帮助治疗肺炎.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 肝纤维化 (LF) 与降低的1型干扰素 (IFN1) 和肠道失调有关.
- 肠道LGR4信号传递对于维持肠道平衡和干细胞至关重要.
研究的目的:
- 研究肠道LGR4信号在肝纤维化中的作用.
- 探索肠道LGR4,肝内微生物群和LF中的IFN1水平之间的关系.
主要方法:
- 碳四化物 (CCL4) 诱导了小鼠的LF,在肠道上皮细胞 (IEC) 中Lgr4的有条件淘汰 (cKO) 或没有条件淘汰.
- 在Lgr4 cKO小鼠中使用了Lactobacillus的胃内给药.
- 分析了肝脏内微生物群和IFN1水平.
主要成果:
- 在LF小鼠中,肠道LGR4的降低与肠道透性增加,细菌转位以及肝脏内IFN1.1的降低相关.
- IECs中的Lgr4 cKO加剧了LF,改变了肝脏内微生物群的组成.
- 在Lgr4 cKO小鼠中,Lactobacillus的使用减弱了LF,恢复了IFN1水平,这种影响取决于IFN1受体.
结论:
- 肠道LGR4信号减弱通过破坏肠道屏障功能和改变肝肠轴来促进LF.
- 肠道LGR4信号影响肝内微生物群和IFN1的产生.
- 针对肠道微生物群,特别是乳酸菌,可以通过调节IFN1反应来为LF提供治疗策略.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35


